Purchases and Sales Made in Q4 2021 in Mirati Therapeutics, Inc. (MRTX)
This table provides information about the institutional ownership of Mirati Therapeutics, Inc. (MRTX) during Q4 2021. The information is specifically focused on institutions that hold shares of Mirati Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2022
Q4 2021
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
BUY
|
- |
480KNew |
$63.3M - $91.3M
|
480K
$0
|
|
Mar 09, 2022
Q4 2021
|
Norges Bank
Oslo, Q8 |
BUY
|
- |
396KNew |
$52.2M - $75.3M
|
396K
$0
|
|
Feb 14, 2022
Q4 2021
|
Ra Capital Management, L.P.
Boston, MA |
BUY
|
- |
381KNew |
$50.3M - $72.5M
|
381K
$0
|
|
Feb 14, 2022
Q4 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
301K+ 7.28% |
$39.8M - $57.3M
|
4.44M
$0
|
|
Feb 10, 2022
Q4 2021
|
Westfield Capital Management CO LP
Boston, MA |
BUY
|
- |
293KNew |
$38.7M - $55.8M
|
293K
$0
|
|
Jan 28, 2022
Q4 2021
|
Allspring Global Investments Holdings, LLC
|
BUY
|
- |
265KNew |
$35M - $50.5M
|
265K
$0
|
|
Feb 14, 2022
Q4 2021
|
Paradigm Biocapital Advisors LP
New York, NY |
BUY
|
- |
260KNew |
$34.3M - $49.5M
|
260K
$0
|
|
Feb 14, 2022
Q4 2021
|
Holocene Advisors, LP
New York, NY |
BUY
|
- |
248K+ 31.26% |
$32.7M - $47.2M
|
1.04M
$0
|
|
Feb 14, 2022
Q4 2021
|
Suvretta Capital Management, LLC
New York, NY |
BUY
|
- |
211K+ 110.54% |
$27.9M - $40.2M
|
403K
$0
|
|
Feb 11, 2022
Q4 2021
|
Artal Group S.A.
Luxembourg, N4 |
BUY
|
- |
200K+ 16.67% |
$26.4M - $38.1M
|
1.4M
$0
|
|
Feb 14, 2022
Q4 2021
|
Eventide Asset Management, LLC
Boston, MA |
BUY
|
- |
162K+ 125.24% |
$21.4M - $30.9M
|
292K
$0
|
|
Feb 14, 2022
Q4 2021
|
Ubs Asset Management Americas Inc
Chicago, IL |
BUY
|
- |
128K+ 31.47% |
$16.9M - $24.4M
|
535K
$0
|
|
Feb 14, 2022
Q4 2021
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
126K+ 17.75% |
$16.6M - $24M
|
836K
$0
|
|
Feb 14, 2022
Q4 2021
|
Camber Capital Management LP
Boston, MA |
BUY
|
- |
125K+ 27.78% |
$16.5M - $23.8M
|
575K
$0
|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
BUY
|
- |
120K+ 13.09% |
$15.8M - $22.8M
|
1.04M
$0
|
|
Feb 10, 2022
Q4 2021
|
Candriam S.C.A.
|
BUY
|
- |
109K+ 28.51% |
$14.4M - $20.8M
|
492K
$0
|
|
Feb 14, 2022
Q4 2021
|
Bamco Inc
New York, NY |
BUY
|
- |
104K+ 461.43% |
$13.7M - $19.8M
|
126K
$0
|
|
Feb 14, 2022
Q4 2021
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
103K+ 66.57% |
$13.7M - $19.7M
|
259K
$0
|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
98.5K+ 3.7% |
$13M - $18.7M
|
2.76M
$0
|
|
Feb 07, 2022
Q4 2021
|
Victory Capital Management Inc
|
BUY
|
- |
90.2KNew |
$11.9M - $17.2M
|
90.2K
$0
|
|
Feb 14, 2022
Q4 2021
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
BUY
|
- |
88KNew |
$11.6M - $16.7M
|
88K
$0
|
|
Feb 11, 2022
Q4 2021
|
Neuberger Berman Group LLC
New York, NY |
BUY
|
- |
87.2KNew |
$11.5M - $16.6M
|
87.2K
$0
|
|
Feb 14, 2022
Q4 2021
|
Avoro Capital Advisors LLC
New York, NY |
BUY
|
- |
75K+ 1.5% |
$9.9M - $14.3M
|
5.08M
$0
|
|
Feb 11, 2022
Q4 2021
|
Sectoral Asset Management Inc
Montreal, A8 |
BUY
|
- |
73.3K+ 2872.83% |
$9.67M - $13.9M
|
75.8K
$0
|
|
Feb 14, 2022
Q4 2021
|
Rtw Investments, LP
New York, NY |
BUY
|
- |
69K+ 4.62% |
$9.1M - $13.1M
|
1.56M
$0
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
BUY
|
- |
60.6K+ 2.87% |
$8M - $11.5M
|
2.17M
$0
|
|
Feb 11, 2022
Q4 2021
|
Bank Of Nova Scotia
|
BUY
|
- |
57.9KNew |
$7.64M - $11M
|
57.9K
$0
|
|
Feb 14, 2022
Q4 2021
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
56.9K+ 16.1% |
$7.51M - $10.8M
|
410K
$0
|
|
Feb 11, 2022
Q4 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
55.1K+ 9.83% |
$7.27M - $10.5M
|
616K
$0
|
|
Feb 14, 2022
Q4 2021
|
First Light Asset Management, LLC
Edina, MN |
BUY
|
- |
55KNew |
$7.26M - $10.5M
|
55K
$0
|
|
Feb 14, 2022
Q4 2021
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
53.2K+ 3.87% |
$7.02M - $10.1M
|
1.43M
$0
|
|
Feb 14, 2022
Q4 2021
|
Fred Alger Management, LLC
New York, NY |
BUY
|
- |
53.2KNew |
$7.02M - $10.1M
|
53.2K
$0
|
|
Feb 14, 2022
Q4 2021
|
Clough Capital Partners L P
Boston, MA |
BUY
|
- |
51.1K+ 103.54% |
$6.75M - $9.72M
|
100K
$0
|
|
Feb 08, 2022
Q4 2021
|
First Trust Advisors LP
Wheaton, IL |
BUY
|
- |
50.7KNew |
$6.7M - $9.66M
|
50.7K
$0
|
|
Feb 10, 2022
Q4 2021
|
Pictet Asset Management Sa
Geneva 73, V8 |
BUY
|
- |
50.2K+ 20.06% |
$6.62M - $9.55M
|
300K
$0
|
|
Feb 14, 2022
Q4 2021
|
Logos Global Management LP
San Francisco, CA |
BUY
|
- |
50KNew |
$6.6M - $9.51M
|
50K
$0
|
|
Feb 14, 2022
Q4 2021
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
49.4K+ 527.95% |
$6.52M - $9.4M
|
58.7K
$0
|
|
Jan 24, 2022
Q4 2021
|
National Bank Of Canada
|
BUY
|
- |
49.1KNew |
$6.49M - $9.35M
|
49.1K
$0
|
|
Feb 14, 2022
Q4 2021
|
Canada Pension Plan Investment Board
Toronto Ontario, A6 |
BUY
|
- |
49KNew |
$6.47M - $9.32M
|
49K
$0
|
|
Feb 11, 2022
Q4 2021
|
Cibc World Markets Corp
New York, NY |
BUY
|
- |
49KNew |
$6.47M - $9.32M
|
49K
$0
|
|
Feb 18, 2022
Q4 2021
|
Comerica Bank
|
BUY
|
- |
47.9KNew |
$6.32M - $9.11M
|
47.9K
$0
|
|
Feb 14, 2022
Q4 2021
|
Jefferies Group LLC
New York, NY |
BUY
|
- |
44.5K+ 1560.16% |
$5.88M - $8.47M
|
47.4K
$0
|
|
Sep 21, 2023
Q4 2021
|
Jefferies Group LLC
New York, NY |
BUY
|
- |
44.5K+ 1560.16% |
$5.88M - $8.47M
|
47.4K
$0
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
43.1K+ 107.21% |
$5.69M - $8.21M
|
83.4K
$0
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
36.9K+ 18.81% |
$4.87M - $7.02M
|
233K
$0
|
|
Feb 11, 2022
Q4 2021
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
35.4K+ 10.2% |
$4.67M - $6.74M
|
382K
$0
|
|
Feb 14, 2022
Q4 2021
|
Driehaus Capital Management LLC
Chicago, IL |
BUY
|
- |
34.6K+ 23.26% |
$4.57M - $6.59M
|
183K
$0
|
|
Feb 14, 2022
Q4 2021
|
Hrt Financial LP
New York, NY |
BUY
|
- |
31.4KNew |
$4.14M - $5.97M
|
31.4K
$0
|
|
Feb 14, 2022
Q4 2021
|
Lombard Odier Asset Management (Switzerland) Sa
Petit Lancy, V8 |
BUY
|
- |
28.6K+ 30.68% |
$3.77M - $5.44M
|
122K
$0
|
|
Feb 15, 2022
Q4 2021
|
International Biotechnology Trust PLC
London, X0 |
BUY
|
- |
28K+ 28.43% |
$3.7M - $5.33M
|
127K
$0
|